N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine

Term ID

CHEBI:136366

Synonyms

(2S,3R,4E)-2-(docosanoylamino)-1-[(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)oxy]octadec-4-en-3-yl acetate
2,3,4,6-beta-tetraacetyl-D-galactosyl-N-(docosanoyl)-3-acetylsphing-4-enine
2,3,4,6-beta-tetraacetyl-D-galactosyl-N-(docosanoyl)-3-acetylsphingosine
3-O-acetyl-sphingosine-2,3,4,6-tetra-O-acetyl-GalCer(d18:1/22:0)
FMC-5(d18:1/22:0)
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphing-4-enine
N-(docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine

Definition

A glycosylceramide obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of 1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine.

References

LIPID_MAPS_instance:LMSP05010034
Reaxys:11241148

Ontology

ChEBI ( EBI )

Relationships

is a type of: cerebroside galactolipid glycosylceramide

cerebroside galactolipid glycosylceramide Show first 5 Terms
has_functional_parent: docosanoic acid

docosanoic acid Show first 5 Terms
has_role: human xenobiotic metabolite

human xenobiotic metabolite Show first 5 Terms

Phenotype

Phenotype resulting from N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine

Phenotype where environments contain N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine

Phenotype modified by environments containing N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine

Human Disease Model